Recently, basf group announced the sale of its construction-chemicals business to Lone Star, an American private equity firm, for 3.17 billion euros, or about $2.46 billion, to be completed in the third quarter of 2020.
The news caused an uproar in the chemical industry. As early as last fall, basf CEO brudermuller said it would spin off the chemical building materials business, citing weak coordination with other businesses and a lack of profitability expectations, according to public sources. According to the coating purchasing network to understand, under the promotion of the overall environment, in 2019, win win, lanxers, acoma, huntsman, shandwei and many other domestic and foreign leading enterprises to part of their business, plant, equipment, and even the subsidiary of the equity divest, sell, and strive for transformation and upgrading, to improve the poor profitability and other conditions.
On December 26, chuanhua zhilian intends to transfer 100% of the shares of its subsidiary company hangzhou zhongcheng supply chain management co., ltd. and 100% of the shares of its subsidiary company shenyang chuanhua highway port logistics co., ltd. to haiyuan trading. Through negotiation, chuanhua zhilian and haiyuan commerce and trade confirmed that the 100% equity transfer price of zhongcheng supply chain was RMB 755.6266 million yuan, and that of shenyang chuanhua 100% equity transfer price was RMB 596.24 million yuan, totaling RMB 81.5891 million yuan.
On December 21, shengjitang issued a notice, intends to sell the subsidiary guizhou chitianhua tongzi chemical co., LTD. 100% equity. The sale of the assets represents the transformation of holy church from a "pharmaceutical + chemical" company into a single-driven pharmaceutical company.
On December 19, clariant had agreed to sell all of its masterbatch business to priwan. The deal is valued at $1.56bn, or about 12.2 times the EBITDA(excluding cash and debt) reported for the past 12 months ending September 2019. The amount is expected to be paid in the third quarter of 2020 upon completion of the transaction.
On December 16th America's Ferro said it would sell its ceramic paint business to a Spanish pigment company, a subsidiary of Lone Star funds' esmalglass-itaca-fritta group, for $460m in cash.
On Dec. 16, dupont sold its nutrition and biosciences division to International Flavors & Fragrances(IFF) for $26.2 billion. Dupont will own 55.4 per cent of the new company, while IFF will own 44.6 per cent. Dupont will receive $7.3bn in cash. IFF expects $300m in synergies in the third year after the acquisition.
On December 14, xuanwei completed the asset sale of zhaoqing xuanwei coating co., LTD., a wholly-owned subsidiary of xuanwei based in zhaoqing, China.
On November 18, Kansai Paint sold its stake in a joint venture in China, closed a factory and exited a business in the country.
Data shows, kansai paint out five companies and 1 project, including: the company has been in September 2019 by selling shares to partner the zhaoqing kansai SAN lian powder coatings co., LTD., is scheduled for December 2019 to kansai paint (China) co., LTD., the implementation of business, plan in December 2019, closing liquidation chongqing beautiful, kansai paint co., LTD. In addition, the PFP project was withdrawn in September and plans were made to discontinue kansai coatings Europe LTD.
On November 15th lanxers announced the sale of 74% of its stake in rustenburg chrome mines in South Africa to Clover Alloys, a South African supplier of chrome powder, and the two companies signed an agreement.
On November 7, baise bear's parent company, Masco, announced the sale of its Milgard doors and Windows business to MI doors and Windows for $725 million. After the sale, musk will be able to focus more on plumbing products and decorative building products (mainly BEHR bear paint).
In November, it completed the sale of its European polyurethane systems business to H.I.G. capital. The deal, valued at close to 100 million euros, includes plants in the Netherlands, Denmark, Spain, Germany and other operations in Italy.
On October 31, clariant announced the successful sale of its medical packaging business to a new company funded by Arsenal Capital Partners, a deal that was signed on July 22, 2019. The total consideration for the sale is about sfr308m, or 13.2 times adjusted earnings before interest, tax, depreciation and amortisation for fy2018.
On October 14, arkema announced plans to spin off its functional polyolefin business into SK Global Chemical. Through this project, acoma further transformed into specialty chemicals and advanced materials.
On October 11, sanaifu (600636.sh) issued a notice that it intends to transfer its three subsidiaries through the property rights exchange, further optimizing the company's asset structure and focusing on the development of culture and education. The sale by sanaifu is changshu sanaifu zhenfluoride new materials co., LTD. 65% of the shares, sanaifu (changshu) new materials co., LTD. 100%, and Shanghai huayi sanaifu new materials sales co., LTD. 100%. If the transaction is completed, sanaifu will no longer operate fluorine chemical business, only education business section.
On September 24th basf will sell its ultrafiltration membrane business to dupont. The divestment includes shares in inge ag, an international sales team responsible for the related businesses, the business headquarters and production base in greifenberg, Germany, and the related intellectual property rights currently held by basf Europe.
September 10, chongqing three gorges (000565) evening announcement said that the company intends to transfer in chongqing united property rights exchange group co. As of May 31, 2019, the estimated value of all shareholders' equity was 245 million yuan.
In September, costron signed an agreement to sell its European polycarbonate (PC) panel business to Serafin group for €130m.
On August 29th basf announced a deal to sell its global pigments business to DIC, a Japanese fine chemicals company. The deal, involving cash and debt-free purchases of 1.15bn, is expected to close in the fourth quarter of this year.
On August 14th basf, solver and dormer agreed to buy solver's European polyamide 66 business. The deal is scheduled to close by the end of 2019, but still needs approval from the relevant competition regulator. Under the agreement signed in September 2017, basf will acquire the global polyamide 66 business outside Europe from solvay, including 50% of adiponitrile (ADN) production from solvay's joint venture plant Butachimie in France.
On August 12, lanxers announced the sale of its chromium chemicals business to Brother Enterprises Holding Co.,Ltd., a Chinese leather chemicals maker. Lanxess expects to close the deal by the end of 2019.
On August 7, huntsman announced that it had reached a definitive agreement with Indorama Ventures to sell its chemical intermediates business and surfactant business, including PO/MTBE. The deal is worth $2.076 billion, including a $2 billion cash offer and net underfunded pension and other post-retirement benefits liabilities of about $76 million. The $2.076bn deal is worth eight times adjusted EBITDA over the past 12 months.
On August 6th bayer and lanxer jointly announced the sale of their shares in Currenta, operator of the chemical park, to a fund managed by Macquarie infrastructure and real estate (MIRA). Currenta is a joint venture between bayer and lanxess, with bayer holding 60 per cent and lanxess 40 per cent. The deal, which includes the transfer of bayer's real estate portfolio, leaves Currenta with a total value of 3.5 billion euros before debt and pension liabilities are deducted.
In August, PolyOne of the us sold its Performance Products&Solutions division to SK Capital Partners for $775m in cash. The division includes one of the largest PVC composite companies in North America. The deal is set to close in the fourth quarter of 2019. The deal, which is expected to close in the third quarter of 2019, is expected to have a pre-tax gain of about $600m, Mr Priwan said.
On July 11th SIGroup announced an agreement. Under the agreement, the company sold the bulk of its global industrial resins business and its Brazilian speciality business to ASKChemicals.
On July 8, bluestar petrochemical plans to transfer 90.47% of bluestar chemical co., LTD. 's equity and 440 million yuan of creditor's rights, with a reserve price of 405.93555 million yuan, starting and ending from July 8, 2019 to August 2, 2019.
On June 27, tiande chemical (00609) announced that the company, which is indirectly wholly-owned by heiderhong chemical industry co., ltd. intends to sell all the shares of jiangsu chunxiao pharmaceutical chemical technology co., ltd. to dou jingzhong for 990,000 yuan.
On June 10, chongqing zoneng chemical co., LTD. 100% equity and related creditor's rights were listed and transferred on the chongqing stock exchange.
On March 4, it signed a deal with Advent International to sell its methacrylate business for 3 billion euros. The price is 8.5 times the business's earnings before interest, tax, depreciation and amortisation. The transaction will include methacrylate, acrylic products, CyPlus product lines and some methacrylate resin businesses. The deal is subject to approvals from authorities in several countries and is expected to close in the third quarter of this year.
In 2019, global markets have been in turmoil and the economic situation has been turbulent. In this year, a lot of chemical giant large layoffs, profits decline, reduce the scale of business news came out one after another, heavy knock chemical people's nerves. Basf, an international chemical company of this level, still sells its ultrafiltration membrane business, pigment business, construction chemicals business, etc., which is called "survival by arms" by many people in the industry, it is not difficult to imagine the situation of other small and medium-sized enterprises. And jiangsu changshu, shandong yantai, hubei wuhan and other places of paint, plastic powder enterprises entrusted paint purchasing network transfer plant information has never been interrupted. They either because of low profits, business is bleak, ready to get out of the "sea of pain" as soon as possible, or insolvency, caught in a lawsuit, had to cut back on business, their own actions, in order to better survival and development.